Posted on November 2, 2009 by emilykaustin
Take a look: http://www.nytimes.com/2009/10/25/business/smallbusiness/25health.html?_r=1&emc=eta1
Sheryl Skolnick teaches the EMPH Master Class “Wall Street and Health Care: The Intersection of Cash and Care.”
Filed under: Uncategorized | Leave a Comment »
Posted on October 9, 2009 by emilykaustin
Posted on October 9, 2009 by emilykaustin
Posted on July 14, 2009 by Richard
I am at the HIT Policy Committee Certification / Adoption Workgroup in Washington DC, blogging from my iPhone.
This two day workgroup meeting is going to discuss the certification process for federal HIT policy.
If you’d like to join, please visit here
More updates to follow. (hopefully with better pictures.)

Filed under: intro to health it | Leave a Comment »
Posted on June 20, 2009 by Richard
The following appeared in The Washington Post Online.
As both a physician and ordained minister, I am often called upon to heal. Whether hearts or bodies, minds or souls, healing is central to both professions. Surprisingly, I heard my President echo the same thought and it struck a chord. He cautioned health-care providers not to see medicine as mere business, a practice model which is rife with hazard. Instead, he romanticized for some and made poignant for us all the call of medicine. Armed with a mix of ego and duty, he championed all stakeholders — specifically physicians — to own the problem so that we may move forward to create solutions.
Physicians take an oath. We are taught to first do no harm. Yet, the American system of health-care delivery is fraught with unchecked abuses and unsustainable damage has been suffered. In society, we aspire to live by the edict of “do unto others as you would have them do unto you.” However, the culture of American medicine is too fragmented, driven by excess, ignorance and complacency. Regrettably, these attitudes have cost efficiency and indulged appetites for pricier, quantitative medical care while sacrificing value. Our system hence is in dire need of more group-accountability, individual responsibility and focus on health promotion, wellness and quality. Read more »
Filed under: Uncategorized | Leave a Comment »
Posted on June 20, 2009 by Richard

Max Nathan Sale born June 18th around 2 pm. 8lbs 11oz a little over 20 inches.
Mom, baby…Chris, Darby and Emily are all doing superb
Filed under: Uncategorized | Leave a Comment »
Posted on June 14, 2009 by Richard

From WhiteHouse.gov:
Sherry Glied, Nominee for Assistant Secretary for Planning and Evaluation, Department of Health and Human Services
Sherry Glied is Professor and Chair in the Department of Health Policy and Management of Columbia University’s Mailman School of Public Health. She has extensive experience in health care financing and mental health policy research. From 1992-1993, she served as a Senior Economist for health care and labor market policy to the President’s Council of Economic Advisers, under President Bush and President Clinton. Professor Glied was a participant in President Clinton’s Health Care Task Force and headed working groups on global budgets and on the economic impacts of the health plan. Her book on health care reform, Chronic Condition, was published by Harvard University Press in January 1998. She also has substantial experience in mental health policy, particularly around issues of child and adolescent mental health policy and financing. Professor Glied is a member of the MacArthur Foundation’s Network on Mental Health Policy and is co-author of Better but Not Well: Mental Health Policy in the US Since 1950, published by Johns Hopkins University Press in July 2006.
Read more »
Filed under: Introduction to Health Economics | Tagged: Barack Obama, HHS, Sherry Glied | Leave a Comment »
Posted on May 22, 2009 by Richard

Click here for more information about the Alumni Summit for Public Health Leadership.
Filed under: Uncategorized | Leave a Comment »
Posted on May 21, 2009 by Richard
Comparative effectiveness research was the big topic at this meeting of pharmacoeconomics and outcomes researchers (www.ispor.org). Speakers at a Tuesday plenary session included Hal Sox, Annals of Internal Medicine editor and chair of the Institute of Medicine (IOM) panel charged with prioritizing areas for the $1.1 billion comparative effectiveness research funding in the stimulus package.
In some sense people here feel that the “comparative effectiveness” moniker is just attaching another word to what
many researchers have been doing all along – finding ways to see how well health care interventions work once they are translated to the “real world” of clinical practice. This is not to say the administration’s policies will not make a difference, however. This kind of research is often conducted using large observational databases rather than a priori controlled trials, so there is a perception that more gaming of the results is possible – payers can get the answers they want from their analysis, while pharmaceutical companies can get the answers they want from competing analysis, sometimes using the same data source.
The big difference that government involvement can make, then, is breaking the stalemate on comparative effectiveness research by requiring projects it funds to be truly transparent: prospective registration of plans for how the analysis will be conducted, for instance, and requirements to make findings publicly available regardless of the result. It remains to be seen what the exact parameters of these projects will be, and whether they will vary across the agencies involved (the funding is split between AHRQ, NIH, and HHS).
The IOM panel’s report on national priorities for research is due out June 30th.
Filed under: Student / Alum | Tagged: Diana Frame, Institute of Medicine, pharmacoeconomics and outcomes researchers | Leave a Comment »